Ally Financial Inc Q2 2025 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Sanjay Sakhrani - Keefe Bruyette & Woods Inc - Analyst : Thank you. Good morning. My first question is on net interest margin. obviously, good traction there. You've had a couple of headwinds and still saw very good performance in NIM. Russ, I got sort of the guidance you gave for the second half. I'm just curious what could lead you to outperform that expectation or underperform that expectation sort of what's baked into your assumptions for the rate outlook the second half? And then just specific to the 4% NIM target, like what's the timeline now that from this point onwards to get there.

Question: Sanjay Sakhrani - Keefe Bruyette & Woods Inc - Analyst : Thank you for the detail explanation, Michael, just one quick one for you. Obviously, credit seems better in control now with the 2022 and '23 vintages kind of performing better. I'm just curious, do you feel like it might be time to lean in a little bit more towards growth? Or do you feel pretty good where you guys are at right now? Just trying to think about if you could get an acceleration in growth as a result of the underwriting stuff that you guys have done? Thanks.

Question: Jeff Adelson - Morgan Stanley - Analyst : Hey, good morning, thanks for taking my questions. I just wanted to circle back on your credit trends. They certainly seem to be improving and inflecting here. I know, Michael, you just talked about some of the roll rates and used car prices. But I guess just affordability concerns aside over the longer medium term. Should we be expecting used car prices to continue to help credit over the back half of the year. And I guess, I think you are still evaluating whether you want to maybe pare back the S-tier a little bit more and get some more yield. But what would be the consideration at hand or the benchmarks you'd look at before you decide you want to lean a little bit back more into that below year tranche.

Question: Jeff Adelson - Morgan Stanley - Analyst : Okay. Great, thanks for that. And if I could just sort of talk about capital return or ask about capital return. You've talked about the higher CET1 levels and consistent organic capital generation is a key factor in determining a return to share repurchase here. It does look like you're very close to that 10% CET1, which is a nice buffer from where you targeted historically. I know you still have that AOCI hit to deal with, but we've been asked by investors if next year's stress test is sort of the right barometer we be thinking about for capital return. Is that necessarily a gating factor you think about? Or maybe just talk a little bit about how you're thinking about capital return over the medium term here?

Question: Ryan Nash - Goldman Sachs - Analyst : Hey, good morning, Michael. Good morning, Russ. Maybe just a follow-up on credit. So it was good to see delinquencies, better delinquency performance. They're now down year-over-year. I guess sort of a two part question, like, Russ, what we need to see? Or what would it take to actually move the charge-off rate range down. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JULY 18, 2025 / 1:00PM, ALLY.N - Q2 2025 Ally Financial Inc Earnings Call And last quarter, you talked about shifting seasonality. Maybe just help us think about seasonality for the back half of the year on losses. Thank you.

Question: Ryan Nash - Goldman Sachs - Analyst : Got it. And maybe as a follow-up, we saw a seasonal declines in the deposit book, but we obviously had really nice repricing. Maybe just talk about the strategy on deposits from here. I know that there's been remixing within the portfolio? And are there further opportunities to optimize? And how are you thinking about the trade-off between growth and price as we look to further easing that could be coming in the back half of the year? Thank you.

Question: Moshe Orenbuch - TD Cowen - Analyst : Great, thanks. And I think the improvement in capital that you've shown has been pretty notable. I guess I'm kind of -- maybe you still talk about using these CRT transactions. I guess it's not clear to me, what those would do for you at this point, given that they have a revenue cost. It seems like the alternative might be to try and continue to chip away at the AOCI and maybe you could talk about how you're thinking about those tools as getting you closer to the point at which you could buy back stock.

Question: Moshe Orenbuch - TD Cowen - Analyst : Got it. And -- sorry for this next one not being or being so kind of technically oriented. But maybe, Russ, could you talk a little bit more about the insurance business and what the renewal kind of means for profitability of the insurance business over the next year? How can you recover that in pricing? And how we should kind of think about that? Thanks.